Answers are grounded in this paper and cite their sources.
Protein-energy wasting syndrome is a determining factor of morbidity and mortality in end stage renal disease (ESRD). Most adults undergoing hemodialysis (HD) show some evidence of muscle wasting. Clinical and experimental studies have suggested that secondary hyperparathyroidism (SHPT) plays a vital role in increasing energy expenditure and protein catabolism in patients with ESRD. Considering these effects, our study aims to investigate if the prevalence of muscle atrophy (MA) is higher in HD patients with SHPT.
No takes yet. Share an insight, caveat, or question.
Cipres et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: